Seiji Yano Selected Research

Seiji Yano Research Topics

Disease

139	Neoplasms (Cancer) 05/2024 - 06/2002
78	Lung Neoplasms (Lung Cancer) 02/2024 - 06/2002
47	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2023 - 06/2002
40	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2002
14	Malignant Mesothelioma 09/2021 - 01/2006
13	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2017 - 01/2003
12	Adenocarcinoma of Lung 02/2023 - 06/2002
8	Pleural Effusion (Pleural Effusions) 12/2022 - 01/2006
7	Carcinoma (Carcinomatosis) 12/2020 - 11/2010
6	Disease Progression 02/2024 - 11/2014
6	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2003
6	Pancreatic Neoplasms (Pancreatic Cancer) 09/2021 - 04/2003
6	Adenocarcinoma 07/2015 - 04/2004
5	Meningeal Carcinomatosis 09/2021 - 10/2009
5	Brain Neoplasms (Brain Tumor) 09/2020 - 01/2002
4	Colonic Neoplasms (Colon Cancer) 01/2023 - 03/2005
4	Peritoneal Neoplasms 01/2022 - 06/2011
4	Prostatic Neoplasms (Prostate Cancer) 10/2021 - 04/2004
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020 - 06/2002
4	Mesothelioma 10/2020 - 06/2002
4	Hemorrhage 07/2019 - 07/2002
4	Malignant Pleural Effusion 02/2007 - 06/2003
3	Body Weight (Weight, Body) 11/2023 - 03/2003
3	Ascites 01/2022 - 06/2011
3	Renal Cell Carcinoma (Grawitz Tumor) 11/2021 - 12/2010
3	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 01/2019
3	Carcinogenesis 12/2020 - 01/2018
3	Breast Neoplasms (Breast Cancer) 12/2013 - 01/2003
3	Neoplasm Micrometastasis 07/2011 - 03/2003
3	Ductal Carcinoma 09/2005 - 04/2003
3	Pancreatic Ductal Carcinoma 09/2005 - 04/2003
2	Cough 03/2024 - 01/2023
2	Nausea 06/2023 - 09/2004

Drug/Important Bio-Agent (IBA)

51	Tyrosine Kinase InhibitorsIBA 02/2024 - 05/2003
45	ErbB Receptors (EGF Receptor)IBA 02/2024 - 01/2003
33	Gefitinib (Iressa)FDA Link 01/2023 - 05/2003
22	Phosphotransferases (Kinase)IBA 05/2024 - 01/2004
20	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2003
18	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 06/2003
17	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2023 - 11/2008
17	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2022 - 11/2008
16	osimertinibIBA 02/2024 - 01/2016
14	CrizotinibIBA 05/2024 - 07/2012
11	alectinibIBA 06/2022 - 07/2014
8	Anaplastic Lymphoma KinaseIBA 01/2023 - 07/2012
8	LigandsIBA 09/2021 - 11/2008
7	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023 - 04/2003
7	Cisplatin (Platino)FDA LinkGeneric 09/2012 - 11/2004
6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2024 - 12/2013
6	tyrosine receptor (receptor, tyrosine)IBA 01/2018 - 07/2013
5	RNA (Ribonucleic Acid)IBA 02/2023 - 04/2017
5	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022 - 01/2006
5	Diphosphonates (Bisphosphonates)IBA 03/2016 - 01/2003
4	Tyrosine (L-Tyrosine)FDA Link 05/2024 - 01/2005
4	Immune Checkpoint InhibitorsIBA 01/2023 - 02/2020
4	Therapeutic UsesIBA 01/2023 - 07/2002
4	entrectinibIBA 01/2023 - 12/2017
4	AfatinibIBA 01/2022 - 03/2012
4	AndrogensIBA 01/2021 - 06/2006
4	Vorinostat FDA Link 02/2020 - 04/2013
4	lenvatinibIBA 07/2019 - 12/2009
4	Bevacizumab (Avastin)FDA Link 12/2015 - 10/2007
4	Neutralizing AntibodiesIBA 09/2012 - 02/2004
4	CytokinesIBA 09/2011 - 03/2003
4	Parathyroid Hormone-Related ProteinIBA 01/2009 - 02/2004
3	trametinibIBA 09/2021 - 01/2018
3	Etoposide (VP 16)FDA LinkGeneric 02/2021 - 11/2003
3	EnzymesIBA 01/2021 - 02/2007
3	Biomarkers (Surrogate Marker)IBA 12/2020 - 09/2011
3	DNA (Deoxyribonucleic Acid)IBA 09/2020 - 04/2004
3	Peptides (Polypeptides)IBA 01/2020 - 10/2009
3	AmphiregulinIBA 01/2020 - 06/2011
3	Histone Deacetylase InhibitorsIBA 01/2020 - 01/2018
3	Docetaxel (Taxotere)FDA Link 10/2019 - 03/2003
3	CateninsIBA 01/2019 - 08/2015
3	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2017 - 07/2012
3	AntibodiesIBA 01/2015 - 12/2011
3	WZ4002IBA 01/2013 - 03/2012
3	Cetuximab (Erbitux)FDA Link 11/2012 - 06/2011
3	YM 529IBA 01/2009 - 01/2003
3	Gemcitabine FDA Link 01/2009 - 08/2005
3	vandetanib (ZD6474)IBA 06/2008 - 12/2005
3	src-Family KinasesIBA 09/2006 - 01/2005
3	N- (2- chloro- 5- methoxyphenyl)- 6- methoxy- 7- ((1- methyl- 4- piperidinyl) methoxy) 4-quinazolinamineIBA 09/2006 - 01/2005
3	Oxygen (Dioxygen)IBA 04/2006 - 07/2002
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2006 - 01/2003
3	Matrix Metalloproteinases (MMPs)IBA 03/2003 - 10/2002
2	Carboplatin (JM8)FDA LinkGeneric 06/2023 - 10/2009
2	B7-H1 AntigenIBA 02/2023 - 08/2021
2	lorlatinibIBA 01/2023 - 01/2019
2	Axitinib (AG 013736)IBA 10/2022 - 01/2020
2	MicroRNAs (MicroRNA)IBA 05/2022 - 10/2019
2	Messenger RNA (mRNA)IBA 01/2022 - 06/2011
2	NivolumabIBA 01/2022 - 12/2020
2	Oncogene Proteins (Oncogene Protein)IBA 01/2022 - 11/2008

Therapy/Procedure

52	Therapeutics 02/2024 - 01/2002
23	Drug Therapy (Chemotherapy) 06/2023 - 07/2002
4	Combination Drug Therapy (Combination Chemotherapy) 12/2020 - 09/2004
3	Aftercare (After-Treatment) 03/2024 - 09/2012
3	Radiotherapy 10/2022 - 08/2005